David Valdecanas
Overview
Explore the profile of David Valdecanas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
808
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Raju U, Ariga H, Koto M, Lu X, Pickett J, Valdecanas D, et al.
Radiother Oncol
. 2006 Aug;
80(2):185-91.
PMID: 16905211
Background And Purpose: Concurrent chemo-radiotherapy before surgery is standard treatment protocol for esophageal cancer with a less than 30% complete response due to resistance to therapy. The aim of this...
12.
Mason K, Ariga H, Neal R, Valdecanas D, Hunter N, Krieg A, et al.
Clin Cancer Res
. 2005 Jan;
11(1):361-9.
PMID: 15671567
Synthetic oligodeoxynucleotides containing unmethylated CpG motifs detected by Toll-like receptor 9 of dendritic cells and B cells have potent immunomodulatory effects. CpG oligodeoxynucleotides induce cytokines, activate natural killer cells, and...
13.
Milas L, Mason K, Ariga H, Hunter N, Neal R, Valdecanas D, et al.
Cancer Res
. 2004 Aug;
64(15):5074-7.
PMID: 15289307
CpG oligodeoxynucleotides (ODNs) are synthetic DNA sequences containing unmethylated cytosine-guanine motifs with potent immunomodulatory effects. Via Toll-like receptor 9 agonism of dendritic cells and B cells, CpG ODNs induce cytokines,...
14.
Mason K, Hunter N, Raju U, Ariga H, Husain A, Valdecanas D, et al.
Int J Radiat Oncol Biol Phys
. 2004 Jul;
59(4):1181-9.
PMID: 15234054
Purpose: Recently we reported that inhibition of cyclin-dependent kinases (cdks) by flavopiridol enhanced the radiation response of murine ovarian carcinoma cells in culture. The purpose of this investigation was to...